Role of fibrillin-1 in protecting against osteoarthritis.
Role of fibrillin-1 in protecting against osteoarthritis.
批准号:
MR/X021068/1
负责人:
Blandine Poulet
金额:
$115.08万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
骨关节炎是英国最常见的关节炎。它会导致关节疼痛和僵硬,尽管一些人的症状可能很轻微,但对其他人来说,疼痛和行动不便妨碍了日常活动。在英国,仅膝关节骨关节炎就影响了18%的45岁以上人群。这个年龄段的英国人口比例正在增长,据预测,到2030年,英国关节炎的护理费用将增长到每年1200亿英镑。骨关节炎是一种退化性疾病,会随着时间的推移而恶化,目前还没有药物可以减缓或阻止骨关节炎的恶化。我们的目标纤维蛋白1 (FBN1)是构成韧带和骨骼等组织结构的网络的关键组成部分。我们最近发现FBN1可能在骨关节炎中起重要作用。除了其他研究小组发现人类骨关节炎中FBN1水平发生变化外,我们还发现FBN1蛋白异常的小鼠早发性骨关节炎,在雄性小鼠中尤为严重。这些发现支持FBN1在骨关节炎中的性别依赖性作用,FBN1对避免关节衰竭至关重要。在这个项目中,我们的目标是确定FBN1的丢失是否会使骨关节炎在触发后变得更糟,或者使关节更容易受到最初的损伤。-确定FBN1引起骨关节炎的机制。-测试防止FBN1分解是否可以保护关节免于恶化的骨关节炎。我们创建了一个团队,他们拥有充分了解FBN1在骨关节炎中的作用所需的各种技能,包括骨关节炎进展生物学方面的专业知识,使用混合工程和生物学方法对人类和动物进行韧带生物学和强度测量,创建并使用小鼠模型来了解骨关节炎和蛋白质分解。我们将产生在整个四肢或部分关节中删除FBN1的小鼠品系,并且还具有比通常形式更难分解的FBN1变体。研究人员将对这些小鼠进行几个月的分析,观察它们的行走步态、一般行为和关节图像,以了解缺乏FBN1/缺乏FBN1分解如何影响关节健康和功能。我们还将使用人类样本来研究FBN1在细胞水平上的作用机制。总之,我们的实验将:-确定FBN1是否仅控制骨关节炎的进展,或者它是否也在起始起作用。这一信息对于确定针对FBN1的治疗时机非常重要。-揭示FBN1丢失加速骨关节炎的机制,从而揭示潜在的治疗靶点。-发现阻止FBN1分解是否是减缓骨关节炎进展的有效潜在策略。我们的工作将为FBN1在骨关节炎中的作用提供新的科学见解。这为未来开发针对这种日益重要的疾病的新疗法铺平了道路。
英文摘要
ImportanceOsteoarthritis is the most common form of arthritis in the UK. It causes joints to become painful and stiff and although symptoms can be mild for some people, for others the pain and mobility issues prevent everyday activities. In the UK osteoarthritis in the knee alone affects 18% of people aged over 45 years. The proportion of the UK population in this age group is growing, and it is predicted that that UK care costs for arthritic conditions will grow to £120 billion per year by 2030. Osteoarthritis is a degenerative condition - one which gets worse over time - and there is currently no drug that can slow or stop osteoarthritis from getting worse.Our goalsThe protein fibrillin-1 (FBN1) is a key component of the network that forms the structure of tissues such as ligaments and bones. We recently discovered that FBN1 may play an important role in osteoarthritis. In addition to other groups' findings that FBN1 levels change in human osteoarthritis, we also found that mice with an abnormal FBN1 protein had early onset osteoarthritis, which was particularly severe in male mice. These findings support a sex-dependent role for FBN1 in osteoarthritis, with FBN1 being critical for avoiding joint failure. In this project we aim to - Define whether loss of FBN1 makes osteoarthritis get worse once it has been triggered or makes joints more susceptible to initial damage in the first place. - Determine the mechanism by which FBN1 causes osteoarthritis. - Test whether preventing FBN1 from breaking down can protect joints from worsening osteoarthritis.Our approachWe have created a team with the range of skills needed to fully understand the role of FBN1 in osteoarthritis, including expertise in the biology of osteoarthritis progression, ligament biology and strength measurements in humans and animals using a mixed engineering and biological approach, creating and using mouse models to understand osteoarthritis and protein breakdown. We will generate mouse strains where FBN1 is deleted in whole limbs or just part of the joint, and also with a variant of FBN1 that is more difficult to break down than the usual form. The mice will be analysed over several months looking at their walking gait, general behaviour, and images of their joints to understand how lack of FBN1/lack of FBN1 breakdown affects joint health and function. We will also use human samples to investigate the mechanism of FBN1 action at a cellular level. ImpactTogether, our experiments will: - determine whether FBN1 controls progression of osteoarthritis only, or whether it also plays a role in initiation. This information is important to determine the timing for treatment targeting FBN1. - unravel the mechanisms by which FBN1 loss accelerates osteoarthritis, and therefore reveal potential targets for therapy. - discover whether preventing FBN1 from breaking down is a valid potential strategy for slowing progression of osteoarthritis.Our work will deliver new scientific insights into the role of FBN1 in osteoarthritis. This paves the way for future work developing new therapies against this increasingly important disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
脱细胞化胞外基质通过fibrillin-1调控干细胞的细胞骨架和YAP/TAZ蛋白促进成软骨分化
-
批准号:CSTB2023NSCQ-MSX0578
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:张营
-
依托单位:
富含Fibrillin 1的组织微环境对成纤维细胞增殖与活化的作用及机制
-
批准号:82100785
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李莉
-
依托单位:
Placensin在人滋养层细胞的生成及其参与子痫前期发生的分子机制研究
-
批准号:32000588
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:于医萍
-
依托单位:
继发于Chiari畸形的脊柱侧凸病因学研究
-
批准号:81171672
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2011
-
负责人:朱泽章
-
依托单位:
Fibrillin在拟南芥植物细胞内的功能以及在甘蓝型油菜中的表达研究
-
批准号:30470927
-
项目类别:面上项目
-
资助金额:22.0万元
-
批准年份:2004
-
负责人:杨毅
-
依托单位: